Inovio Pharmaceuticals, Inc. (INO)
1.27
+0.01
(+0.79%)
USD |
NASDAQ |
May 27, 11:54
Inovio Pharmaceuticals Cash from Investing (Quarterly) : 2.636M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| ADMA Biologics, Inc. | 2.404M |
| Agenus, Inc. | 68.95M |
| Vaxart, Inc. | -0.676M |
| Allogene Therapeutics, Inc. | -29.59M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.59M |
| Cash from Financing (Quarterly) | 0.9538M |
| Free Cash Flow | -83.57M |
| Free Cash Flow Per Share (Quarterly) | -0.3125 |
| Free Cash Flow to Equity (Quarterly) | -20.92M |
| Free Cash Flow to Firm (Quarterly) | -21.59M |
| Free Cash Flow Yield | -114.9% |